compounding glp-1 news New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Compounded" GLP-1 drugs | Health
Description
Transform your health with Saxenda, Ozempic, Wegovy & Trulicity

Notably, patients on GLP-1 RAs exhibited a 195% higher risk of major depression, a 108% increased risk for anxiety, and a 106% elevated risk for suicidal behavior
What happens if I quit

Matthew Holt explains GLP-1 weight loss medications, their safety, side effects, diet tips, and how they compare to older weight loss drugs.

#ADA2025 #ADASciSessions | 10 comments on LinkedIn
